Kairos Pharma
Los Angeles
About Kairos Pharma
Kairos Pharma is a clinical-stage biopharmaceutical company focused on cancer immunotherapy and drug resistance. The company operates on the development of peptide and small molecule cancer immunotherapeutic drug candidates.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $80.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2026)
- Ticker: nysemkt:KAPA
- Website: kairospharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kairos-pharma-35226 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.